Namida Lab

Namida Lab, founded in 2019 and headquartered in Fayetteville, Arkansas, is a biotechnology company dedicated to developing rapid healthcare solutions. The company's core mission is to bridge innovative scientific advancements with improved health outcomes. Namida Lab specializes in cancer screening technologies, notably offering the first at-home tear-based breast cancer screening test, Auria, which empowers women to monitor their breast health. Additionally, they provide Melody, a clinical tear-based screening test designed for use in diagnostic clinics without the need for specialized equipment.

Notable figures associated with Namida Lab include its team of experienced scientists and healthcare professionals who drive the company's research and development efforts. The company has garnered attention from investors interested in pioneering healthcare innovations. Key achievements include the successful launch of their tear-based cancer screening products, which have the potential to revolutionize early cancer detection and significantly impact public health by making screenings more accessible and less invasive.